Month: May 2025

May 16 2025

Uncategorized

Newborn vitamin D deficiency linked to higher risk of ADHD, schizophrenia and autism

by Clinical Editor

No Comments

Newborn babies with a vitamin D deficiency have a higher chance of later developing mental disorders such as ADHD, schizophrenia and autism, a major study involving the University of Queensland...

May 16 2025

Uncategorized

Urgent search for missing 24-year-old pregnant woman; Mattie’s Call issued

by Clinical Editor

No Comments

Amanda Tallent, a 24-year-old pregnant woman with schizophrenia, is missing and a Mattie’s Call has been issued.

May 15 2025

Uncategorized

‘Vulnerable adult’ with schizophrenia missing for weeks; police seek public’s help

by Clinical Editor

No Comments

A woman diagnosed with schizophrenia and described as a “vulnerable adult” has been missing for several weeks from Southfield, and police are asking for the public’s help in locating her....

May 15 2025

Uncategorized

Schizophrenic man who stabbed neighbour with screwdriver detained under mental health act

by Clinical Editor

No Comments

A man suffering from schizophrenia repeatedly stabbed his neighbour in the chest and arm, with a screwdriver. Isaac Douglas, 56, called round to ask his neighbour on Thorntree Court in...

May 14 2025

Uncategorized

Intranasal delivery of blackberry-loaded Chitosan nanoparticles for antipsychotic potential in Ketamine-induced schizophrenia in rats – Nature

by Clinical Editor

No Comments

Intranasal delivery of blackberry-loaded Chitosan nanoparticles for antipsychotic potential in Ketamine-induced schizophrenia in rats  Nature

May 14 2025

Uncategorized

SBU News: Schizophrenia expert receives national honor from the American Psychiatric Association – TBR News Media

by Clinical Editor

No Comments

SBU News: Schizophrenia expert receives national honor from the American Psychiatric Association  TBR News Media

May 13 2025

Uncategorized

Phase 3 Development Plan for Evenamide as Add-On Therapy for Treatment-Resistant Schizophrenia – Psychiatric Times

by Clinical Editor

No Comments

Phase 3 Development Plan for Evenamide as Add-On Therapy for Treatment-Resistant Schizophrenia  Psychiatric Times

May 13 2025

Uncategorized

Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS) – BioSpace

by Clinical Editor

No Comments

Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)  BioSpace

May 12 2025

Uncategorized

Schizophrenia may accelerate brain ageing, new study finds

by Clinical Editor

No Comments

Current theories about why schizophrenia develops suggest it may be linked to changes in brain development during this critical period of emerging adulthood. Schizophrenia is also thought to be …

May 12 2025

Uncategorized

BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

by Clinical Editor

No Comments

Net Loss: BioXcel Therapeutics had a net loss of $7.3 million for the first quarter of 2025, compared to a net loss of $26.8 million for the same period in...